Diana Hanekamp - Concepedia

Author

Diana Hanekamp

Amsterdam UMC Location Vrije Universiteit Amsterdam ORCID

Also Known As

D Hanekamp, D. Hanekamp, Diana Hanekamp, Diana W. Hanekamp

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Erasmus MC Erasmus MC Cancer Institute Radboud University Nijmegen Amsterdam University Medical Centers

About

Diana Hanekamp is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in health sciences, medicine, and stem cell research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	4	4	327
2	Medicine	4	4	327
3	Immunology	4	4	327
4	Biostatistics	2	2	61
5	Cell Biology	2	2	266

Diana Hanekamp

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Molecular Minimal Residual Disease in Acute Myeloid Leukemia Mojca Jongen‐Lavrencic, Tim Grob, Diana Hanekamp, New England Journal of Medicine	2018	756
CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia Wendelien Zeijlemaker, Tim Grob, Rosa Meijer, Leukemia Hematological MalignancyMedicineAcute Myeloid LeukemiaStem CellsImmunology	2018	200
Diet-Derived Short Chain Fatty Acids Stimulate Intestinal Epithelial Cells To Induce Mucosal Tolerogenic Dendritic Cells Gera Goverse, Rosalie Molenaar, Laurence Macia, The Journal of Immunology	2017	194
Prognostic Value of <i>FLT3</i>-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia Tim Grob, Mathijs A. Sanders, Christian M. Vonk, Journal of Clinical Oncology	2022	128
PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models Fan Lin, Mark C. de Gooijer, Diana Hanekamp, Clinical Cancer Research	2016	80
<scp>CD</scp>45<scp>RA</scp>, a specific marker for leukaemia stem cell sub‐populations in acute myeloid leukaemia Bas Kersten, Matthijs Valkering, Rolf Wouters, British Journal of Haematology ImmunologyTumor BiologyMyeloid NeoplasiaHematological MalignancyHematology	2016	66
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia Jacqueline Cloos, Jeffrey R. Harris, Jeroen J. W. M. Janssen, Journal of Visualized Experiments Mixed-phenotype Acute LeukemiaImmunologyPathologyResponse CriteriaHematological Malignancy	2018	36
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia Jacqueline Cloos, Jeffrey R. Harris, Jeroen J. W. M. Janssen, Journal of Visualized Experiments Mixed-phenotype Acute LeukemiaImmunologyPathologyResponse CriteriaHematological Malignancy	2018	25
Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression Margot F. van Spronsen, Diana Hanekamp, Theresia M. Westers, Leukemia	2023	18
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting Diana Hanekamp, Alexander N. Snel, Angèle Kelder, British Journal of Haematology	2020	17

Page 1